83 related articles for article (PubMed ID: 7985099)
21. Use of intraoperative ultrasonography to localize islet cell tumors.
Zeiger MA; Shawker TH; Norton JA
World J Surg; 1993; 17(4):448-54. PubMed ID: 8395749
[TBL] [Abstract][Full Text] [Related]
22. Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide.
Nocaudie-Calzada M; Huglo D; Deveaux M; Carnaille B; Proye C; Marchandise X
J Nucl Med; 1994 Jan; 35(1):57-62. PubMed ID: 8271061
[TBL] [Abstract][Full Text] [Related]
23. Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas.
Thompson NW; Czako PF; Fritts LL; Bude R; Bansal R; Nostrant TT; Scheiman JM
Surgery; 1994 Dec; 116(6):1131-8. PubMed ID: 7985098
[TBL] [Abstract][Full Text] [Related]
24. Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.
Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
Ann Surg; 2003 May; 237(5):650-7; discussion 657-9. PubMed ID: 12724631
[TBL] [Abstract][Full Text] [Related]
25. Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor.
Anlauf M; Enosawa T; Henopp T; Schmitt A; Gimm O; Brauckhoff M; Dralle H; Musil A; Hauptmann S; Perren A; Klöppel G
Am J Surg Pathol; 2008 Jul; 32(7):1101-5. PubMed ID: 18520436
[TBL] [Abstract][Full Text] [Related]
26. In-111 pentetreotide. Superior imaging agent for gastrinomas.
McCown JS; Gordon L; Uflacker RP
Clin Nucl Med; 1995 Oct; 20(10):896-8. PubMed ID: 8616995
[TBL] [Abstract][Full Text] [Related]
27. [Somatostatin receptor scintigraphy in neuroendocrine tumors exemplified by a patient with hepatic metastases of gastrinoma].
Behr T; Becker W; Koch W; Grebmeier J; Wolf F
Z Gastroenterol; 1994 Feb; 32(2):100-4. PubMed ID: 7513113
[TBL] [Abstract][Full Text] [Related]
28. In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine.
Bergström M; Eriksson B; Oberg K; Sundin A; Ahlström H; Lindner KJ; Bjurling P; Långström B
J Nucl Med; 1996 Jan; 37(1):32-7. PubMed ID: 8543997
[TBL] [Abstract][Full Text] [Related]
29. Five-Year Long-Term Followup of a Primary Lymph node Gastrinoma: Is a Pancreaticoduodenectomy Justified?
Jaenigen B; Kayser G; Steinke B; Thomusch O
Case Rep Med; 2009; 2009():762791. PubMed ID: 19724657
[TBL] [Abstract][Full Text] [Related]
30. Apparent lymph node primary gastrinoma.
Arnold WS; Fraker DL; Alexander HR; Weber HC; Norton JA; Jensen RT
Surgery; 1994 Dec; 116(6):1123-9; discussion 1129-30. PubMed ID: 7985097
[TBL] [Abstract][Full Text] [Related]
31. [Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy].
Carnaille B
Ann Chir; 2000 Jul; 125(6):595-6. PubMed ID: 10986776
[No Abstract] [Full Text] [Related]
32. Disease Control on Lanreotide Autogel® 120 mg in a Patient with Metastatic Gastrinoma: A Case Report.
Aerts M; Reynaert H
Case Rep Gastroenterol; 2017; 11(3):616-623. PubMed ID: 29430219
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in the localization and surgical management of duodenal gastrinomas.
Lawton GP; Modlin IM
Curr Opin Gen Surg; 1994; ():131-7. PubMed ID: 7583948
[TBL] [Abstract][Full Text] [Related]
34. 111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors.
Nauck C; Ivancević V; Emrich D; Creutzfeldt W
Z Gastroenterol; 1994 Jun; 32(6):323-7. PubMed ID: 7975760
[TBL] [Abstract][Full Text] [Related]
35. The significance of gastrinomas found in peripancreatic lymph nodes.
MacGillivray DC; Rushin JM; Zeiger MA; Shakir KM
Surgery; 1991 Apr; 109(4):558-62. PubMed ID: 1848952
[TBL] [Abstract][Full Text] [Related]
36. [Receptor scintigraphy in endocrine gastrointestinal and pancreatic tumors].
Joseph K; Stapp J; Reinecke J; Höffken H; Benning R; Neuhaus C; Trautmann ME; Schwerk WB; Arnold R
Dtsch Med Wochenschr; 1992 Jun; 117(26):1025-8. PubMed ID: 1352234
[No Abstract] [Full Text] [Related]
37. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.
Virgolini I; Raderer M; Kurtaran A; Angelberger P; Banyai S; Yang Q; Li S; Banyai M; Pidlich J; Niederle B; Scheithauer W; Valent P
N Engl J Med; 1994 Oct; 331(17):1116-21. PubMed ID: 7935635
[TBL] [Abstract][Full Text] [Related]
38. Gastrinomas: localization by means of selective intraarterial injection of secretin.
Doppman JL; Miller DL; Chang R; Maton PN; London JF; Gardner JD; Jensen RT; Norton JA
Radiology; 1990 Jan; 174(1):25-9. PubMed ID: 2294556
[TBL] [Abstract][Full Text] [Related]
39. Transhepatic portal vein catheterization for localization of sporadic and MEN gastrinomas: a ten-year experience.
Vinik AI; Moattari AR; Cho K; Thompson N
Surgery; 1990 Mar; 107(3):246-55. PubMed ID: 1968682
[TBL] [Abstract][Full Text] [Related]
40. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.
Tonelli F; Fratini G; Nesi G; Tommasi MS; Batignani G; Falchetti A; Brandi ML
Ann Surg; 2006 Jul; 244(1):61-70. PubMed ID: 16794390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
